Lycopus lucidus
Lycopus lucidus · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Lycopus lucidus is a botanical species recognized for its diverse range of therapeutic activities, including anthelmintic, antibacterial, anticancer, and anti-HIV properties. The plant contains key chemical compounds such as rosmarinic acid (RA) that contribute to its medicinal potency. Various preparation methods, including water extracts and specific extracted fractions like F04-A and F04-B, are utilized to harness these benefits. Research suggests that the plant can be effective in addressing health conditions such as edema, poor blood circulation, and irregular menstruation. Furthermore, it shows promise in providing relief for menstrual pain, highlighting its significant pharmacological potential.
- Synonyms
- Phytosalpinx Lucida
- Common names
- Not available
- Family
- Lamiaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Lycopus lucidus is a versatile botanical species known by a wide variety of names across different cultures and languages. In many regions, it is commonly referred to as shiny bugleweed or karbinec svietivý. Its linguistic diversity extends into East Asia, where it is recognized by the names di gua er miao, di sun, and shiro-ne. These overlapping common names highlight the plant's widespread presence and historical importance in various herbal traditions. Understanding these multiple identities is essential for anyone studying the global distribution of this unique herb.
Sources: Catalogue of Life (COL)
Synonyms
Lycopus lucidus is a botanical species that is frequently identified by its scientific synonym, Phytosalpinx lucida. Understanding these nomenclatural connections is essential for researchers navigating complex plant databases. While the names may appear different, they refer to the exact same biological entity within the plant kingdom. This synonymy ensures that botanical records remain consistent across various academic publications. Recognizing these overlapping identities allows for more accurate classification and study of the species.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Lycopus lucidus is a member of the diverse kingdom Plantae. Within this vast kingdom, the plant is categorized under the class Equisetopsida. It belongs to the specific order Lamiales, which helps define its structural characteristics. Further classification places the species within the family Lamiaceae. Finally, it is identified by its distinct genus, Lycopus.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Lamiaceae |
| Genus | Lycopus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Lycopus lucidus is a plant species primarily found throughout the Asia-Temperate region. Within China, its distribution is quite extensive, covering the North-Central and South-Central territories. It also flourishes across the vast landscapes of Inner Mongolia and the Manchuria region. Beyond mainland China, the species extends its reach into Eastern Asia, specifically inhabiting Japan. This widespread presence highlights the plant's ability to adapt to various environments across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Lycopus lucidus is a distinct herb characterized by its sturdy, self-supporting growth form. This plant typically maintains a modest stature, with heights ranging from a minimum of 0.15 meters to a maximum of 1 meter. Depending on its specific environmental conditions, it can grow as small as 0.15 meters or reach up to a full meter in height. Because it is self-supporting, it stands upright without the need for external structural assistance. Ultimately, these physical dimensions define its presence within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Lycopus lucidus has demonstrated significant therapeutic potential due to its inherent antifibrotic activity. As a member of the Lamiaceae family, this plant contains rosmarinic acid, which plays a crucial role in combating organ fibrosis. Research indicates that extracts from this species can help attenuate the hardening and functional degeneration of the liver, kidneys, heart, and lungs in experimental models. These protective effects are achieved by reducing oxidative stress, inflammation, and the expression of fibrogenic genes. Ultimately, Lycopus lucidus serves as a promising natural resource for maintaining organ architecture under pathological conditions.
Compounds
Lycopus lucidus is identified as a significant member of the Lamiaceae family that contains the bioactive compound rosmarinic acid (RA). As a plant rich in this specific acid, it plays a vital role in the potential treatment of fibrosis across various organs. Research indicates that the presence of RA in such extracts helps attenuate the structural hardening and functional degeneration caused by excessive collagen accumulation. These antifibrotic effects are achieved by suppressing key signaling pathways and reducing oxidative stress and inflammation. Ultimately, the inclusion of Lycopus lucidus in herbal studies highlights the therapeutic promise of Lamiaceae plants in maintaining organ health.
Conditions
Lycopus lucidus serves as a therapeutic agent that inhibits osteoclastogenesis and protects against bone loss in osteoporosis models. This perennial herb is traditionally utilized to treat edema and various gynecological conditions. Research indicates that specific extracted fractions of the plant can promote blood circulation by inhibiting platelet aggregation and prolonging coagulation time. Additionally, the plant has demonstrated the ability to attenuate fibrosis of the abdomen in experimental animal models. These diverse medicinal properties highlight its significant potential in addressing both skeletal and systemic health issues.
Preparations
Lycopus lucidus is prepared as extracted fraction F04-A, which has been shown to inhibit platelet aggregation and promote blood circulation. The plant is also prepared as extracted fraction F04-B, a component that similarly affects coagulation functions and may be slightly less active than F04-A. Additionally, Lycopus lucidus is prepared as various extracts that contain rosmarinic acid to help attenuate fibrosis in various organs. The plant is further prepared as a water extract, which has demonstrated the ability to inhibit osteoclastogenesis and protect against bone loss in osteoporosis models. These different preparation methods highlight the diverse therapeutic potential of the species in treating coagulation, fibrosis, and bone health.